Skip to main content
. 2016 Nov 8;73(2):215–221. doi: 10.1007/s00228-016-2152-8

Table 1.

Data on women (n = 5615) and men (n = 6600) aged 45+ years with a diagnosis of atrial fibrillation and without (n = 12,121) or with (n = 162) a hemorrhagic stroke (HS) in primary care from January 1, 2001, to December 31, 2007

Women Men
Without HS With HS Without HS With HS
n = 5548 n = 67 p value n = 6505 n = 95 p value
Age (years), mean (SD) 77.1 (9.3) 77.3 (7.2) 0.80 72.1 (10.2) 75.2 (9.0) 0.0032
Age group (years) 0.28 0.067
n (%) n (%) n (%) n (%)
 45–54 104 (1.9) 0 (0.0) 368 (5.7) 1 (1.1)
 55–64 516 (9.3) 4 (6.0) 1205 (18.5) 12 (12.6)
 65–74 1246 (22.5) 16 (23.9) 1994 (30.7) 32 (33.7)
 75–84 2488 (44.8) 37 (55.2) 2287 (35.2) 35 (36.8)
 85+ 1194 (21.5) 10 (14.9) 651 (10.0) 15 (15.8)
Neighborhood SES 0.13 0.25
 High 1921 (34.6) 16 (23.9) 2597 (39.9) 41 (43.2)
 Middle 2734 (49.3) 36 (53.7) 2966 (45.6) 46 (48.4)
 Low 893 (16.1) 15 (22.4) 942 (14.5) 8 (8.4)
Marital status 0.41 0.40
 Married 1643 (29.8) 14 (20.9) 3865 (59.7) 62 (65.3)
 Unmarried 391 (7.1) 6 (9.0) 617 (9.5) 8 (8.4)
 Divorced 780 (14.1) 12 (17.9) 1002 (15.5) 9 (9.5)
 Widowed 2708 (49.0) 35 (52.2) 996 (15.4) 16 (16.8)
Educational level 0.48 0.58
 Compulsory school 2561 (52.6) 29 (48.3) 2433 (39.5) 34 (39.5)
 Secondary school 1598 (32.8) 24 (40.0) 2318 (37.6) 36 (41.9)
 College/university 712 (14.6) 7 (11.7) 1410 (22.9) 16 (18.6)
AF-related disease
 Hypertension 2706 (48.8) 39 (58.2) 0.13 2694 (41.4) 39 (41.1) 0.58
 CHD 1156 (20.8) 15 (22.4) 0.76 1314 (20.2) 18 (19.0) 0.76
 Heart failure 1140 (20.6) 8 (11.9) 0.082 1127 (17.3) 22 (23.2) 0.14
 Valvular disease 272 (4.9) 4 (6.0) 0.57 288 (4.4) 3 (3.2) 0.80
 Diabetes mellitus 1076 (19.4) 12 (17.9) 0.76 1284 (19.7) 16 (16.8) 0.48
Drugs
 Ever warfarin 2651 (47.8) 38 (56.7) 0.15 3651 (56.1) 57 (60.0) 0.45
 Warfarin ITT 2568 (46.3) 38 (56.7) 0.089 3541 (54.4) 57 (60.0) 0.28
 Warfarin PP 2015 (36.3) 23 (34.3) 0.74 2763 (42.5) 42 (44.2) 0.73
 Ever ASA 3242 (58.4) 36 (53.7) 0.44 3416 (52.5) 53 (55.8) 0.53
 ASA ITT 2863 (51.6) 31 (46.3) 0.39 3007 (46.2) 45 (47.4) 0.83
 ASA PP 1780 (32.1) 16 (23.9) 0.15 1924 (29.6) 25 (26.3) 0.49
 Ever clopidogrel 195 (3.5) 0 0.17 202 (3.1) 3 (3.2) 0.77
 Clopidogrel ITT 141 (2.5) 0 0.42 159 (2.4) 3 (3.2) 0.51
 Clopidogrel PP 61 (1.1) 0 1.0 61 (0.9) 1 (1.1) 0.60

Prescription of antithrombotic drug was classified as “intention to treat” (ITT) if ever present before the year of the first stroke or present among subjects not experiencing a stroke and classified as “per protocol” (PP) if present the year before and the year of first stroke or present among subjects not experiencing a stroke if present at least during 3 years, of at least 50 % of actual years after the first recorded year of AF or during both 2006 and 2007